Japan Single-Use Bioprocessing Market Expected to Reach USD 5,815.8 Million by 2033 - IMARC Group

Japan Single-Use Bioprocessing Market Statistics, Outlook and Regional Analysis 2025-2033

The Japan single-use bioprocessing market size was valued at USD 1,241.4 Million in 2024, and it is expected to reach USD 5,815.8 Million by 2033, exhibiting a growth rate (CAGR) of 16.7% from 2025 to 2033.

Japan's single-use bioprocessing market is advancing with innovations like compact cell expansion systems featuring disposable culture bags and integrated sensors. These solutions support sterile, closed-system environments, addressing growing needs in cell and gene therapy development and manufacturing. For example, PHC Corporation, headquartered in Japan, unveiled the LiCellGrow cell expansion system. It features advanced single-use culture bags with built-in sensors designed to streamline cell culture processes within a closed and sterile environment.

Additionally, the country is witnessing rapid advancements in regenerative medicine, particularly in the adoption of single-use bioprocessing technologies for cell-based therapies. These innovations are enabling more efficient and scalable production processes while maintaining high standards of sterility and precision. The focus is on addressing critical medical conditions, such as corneal diseases, with transformative therapies. As the healthcare sector prioritizes cutting-edge solutions, the shift towards single-use systems supports the growing demand for personalized treatments and improved patient outcomes in the biopharmaceutical industry. For instance, in September 2024, Aurion Biotech introduced Vyznova in Japan. Besides this, favorable government policies, increased funding for biopharmaceutical research, and initiatives to advance biologics manufacturing are fostering industry’s expansion. These measures encourage innovation, streamline production processes, and promote the adoption of advanced technologies, such as single-use systems, to meet the rising demand for biopharmaceuticals. Additionally, government-backed collaborations between academia and industry further accelerate the development of cutting-edge solutions, thereby enhancing scalability and efficiency.

Japan Single-Use Bioprocessing Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Kanto region, Kansai/Kinki region, Central/ Chubu region, Kyushu-Okinawa region, Tohoku region, Chugoku region, Hokkaido region, and Shikoku region. The rise in chronic illnesses and the growing need for biologics, including vaccines, are driving the widespread use of single-use bioprocessing technologies.

Kanto Region Single-Use Bioprocessing Market Trends:

The rising advancements in regenerative medicine across the Kanto region are driving the market expansion. For example, the commercial launch of Vyznova® in Japan marks a significant step forward in utilizing innovative bioprocessing solutions for personalized cell therapies, further accelerating market demand. Moreover, single-use bioprocessing systems are increasingly adopted here, driven by Tokyo-based biotech startups and pharmaceutical giants. Various companies across this region are utilizing these technologies to simplify production processes for monoclonal antibodies.

Kansai/Kinki Region Single-Use Bioprocessing Market Trends:

The rising demand for regenerative medicine in cell and gene therapy development is driving the market growth in the Kansai/Kinki region. Moreover, single-use bioprocessing systems are in high demand in Osaka. Besides this, various research centers are adopting these technologies to develop treatments for diseases like cancer.

Central/Chubu Region Single-Use Bioprocessing Market Trends:

The Central/Chubu region's strong industrial base is elevating the market in the country. Various companies in cities like Nagoya are increasingly adopting single-use technologies to improve the production of biologics. This shift is helping the market growth in Central/Chubu region.

 Kyushu-Okinawa Region Single-Use Bioprocessing Market Trends:

The Kyushu-Okinawa region is focusing on bioprocessing innovations to support the production of biologics for infectious diseases. Various biotech companies based in Fukuoka are utilizing single-use systems to treat dengue. The area's emphasis on fostering international collaboration, coupled with its strategic location, is acting as another growth-inducing factor.

Tohoku Region Single-Use Bioprocessing Market Trends:

The Tohoku region is leveraging single-use bioprocessing technologies for research of biologics. Various institutions in Sendai are driving advancements in biopharmaceuticals, especially in producing cell therapies. This region’s focus on sustainability aligns with single-use systems, which reduce water and energy consumption, thereby further escalating the market growth.

Chugoku Region Single-Use Bioprocessing Market Trends:

The Chugoku region is becoming a growing center for biopharmaceutical advancements aimed at treating age-related diseases. Various companies in Hiroshima are increasingly turning to single-use bioprocessing systems to develop treatments for chronic conditions. Single-use technologies offer a practical solution, allowing companies to manufacture these therapies quickly and flexibly. 

Hokkaido Region Single-Use Bioprocessing Market Trends:

Hokkaido is focusing on single-use bioprocessing systems in agricultural biotechnology. Various research centers based in Sapporo are utilizing biologics for animal health with single-use systems. The growing emphasis across the region supports sustainable farming practices, further proliferating the market growth.

Shikoku Region Single-Use Bioprocessing Market Trends:

The Shikoku region is adopting single-use bioprocessing technologies to boost its small but growing biotech sector. Various companies in Tokushima are focusing on niche biologics, such as enzyme therapies. The flexibility of single-use systems allows for efficient production of these specialized products in smaller facilities.

Top Companies Leading in the Japan Single-Use Bioprocessing Industry

The report includes an in-depth evaluation of the competitive landscape, covering aspects such as market structure, the positioning of key players, top strategies for success, a competitive dashboard, and the company evaluation quadrant. Additionally, it features detailed profiles of all major industry players, offering valuable insights into their operations and strategies. For instance, in January 2024, AGC Biologics launched a new manufacturing facility in Japan to enhance its biopharmaceutical expertise. Besides this, PHC Corporation, headquartered in Japan, unveiled the LiCellGrow cell expansion system.

Japan Single-Use Bioprocessing Market Segmentation Coverage

• On the basis of the product type, the market has been bifurcated into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others. These product variants are designed to enhance the efficiency of biopharmaceutical manufacturing. Apart from this, they aid in offering enhanced deployment and minimized contamination risk.
• Based on the application, the market has been bifurcated into filtration, storage, cell culture, mixing, and purification. These processes are essential in biopharmaceutical production, particularly in the single-use bioprocessing market. Moreover, the elevating need for validation and cleaning between batches is elevating the segment’s growth.
• On the basis of the workflow, the market has been bifurcated into upstream, fermentation, and downstream. Upstream refers to the initial phase, where raw materials, such as media and cells, are prepared and cultured. Moreover, fermentation is a critical bioprocess where microorganisms or cells are cultured to produce desired bioproducts, such as proteins, enzymes, or vaccines.
• Based on the end user, the market has been bifurcated into biopharmaceutical manufacturers, life science R and D, and others. Single-use systems, such as disposable bioreactors, provide flexible solutions for biopharmaceutical manufacturers. Moreover, in research and development, single-use bioprocessing systems allow for rapid prototyping and customization of conditions for cell culture.

Browse IMARC Related Reports on Single-Use Bioprocessing Market

• Single-Use Bioprocessing Market Report